본문 바로가기
KERD
논문KCI 등재

The Role of Upper Airway Microbiome in the Development of Adult Asthma

김세훈|장윤석|최준표|푸제
대한면역학회 (The Korean Association of Immunologists)|2021.06|Immune Network|제21권 제3호|pp. 1-18|DOI 10.4110/in.2021.21.e19

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

AsthmaInflammationMicrobiomeEosinophilsNeutrophils16S rRNA

초록

Clinical and molecular phenotypes of asthma are complex. The main phenotypes of adult asthma are characterized by eosinophil and/or neutrophil cell dominant airway inflammation that represent distinct clinical features. Upper and lower airways constitute a unique system and their interaction shows functional complementarity. Although human upper airway contains various indigenous commensals and opportunistic pathogenic microbiome, imbalance of this interactions lead to pathogen overgrowth and increased inflammation and airway remodeling. Competition for epithelial cell attachment, different susceptibilities to host defense molecules and antimicrobial peptides, and the production of proinflammatory cytokine and pattern recognition receptors possibly determine the pattern of this inflammation. Exposure to environmental factors, including infection, air pollution, smoking is commonly associated with asthma comorbidity, severity, exacerbation and resistance to anti-microbial and steroid treatment, and these effects may also be modulated by host and microbial genetics. Administration of probiotic, antibiotic and corticosteroid treatment for asthma may modify the composition of resident microbiota and clinical features. This review summarizes the effect of some environmental factors on the upper respiratory microbiome, the interaction between host-microbiome, and potential impact of asthma treatment on the composition of the upper airway microbiome.

Abstract

Clinical and molecular phenotypes of asthma are complex. The main phenotypes of adult asthma are characterized by eosinophil and/or neutrophil cell dominant airway inflammation that represent distinct clinical features. Upper and lower airways constitute a unique system and their interaction shows functional complementarity. Although human upper airway contains various indigenous commensals and opportunistic pathogenic microbiome, imbalance of this interactions lead to pathogen overgrowth and increased inflammation and airway remodeling. Competition for epithelial cell attachment, different susceptibilities to host defense molecules and antimicrobial peptides, and the production of proinflammatory cytokine and pattern recognition receptors possibly determine the pattern of this inflammation. Exposure to environmental factors, including infection, air pollution, smoking is commonly associated with asthma comorbidity, severity, exacerbation and resistance to anti-microbial and steroid treatment, and these effects may also be modulated by host and microbial genetics. Administration of probiotic, antibiotic and corticosteroid treatment for asthma may modify the composition of resident microbiota and clinical features. This review summarizes the effect of some environmental factors on the upper respiratory microbiome, the interaction between host-microbiome, and potential impact of asthma treatment on the composition of the upper airway microbiome.

참고문헌 (111)

  1. The Global Asthma Report, "Global Asthma Network", Global Asthma Network, ~ (2018)
  2. Kang SY, "Time trends of the prevalence of allergic diseases in Korea : a systematic literature review", Asia Pac Allergy, 8, pp.e8~ (2018)
  3. Pakkasela J, "Age-specific incidence of allergic and non-allergic asthma", BMC Pulm Med, 20, pp.9~ (2020)
  4. Song WJ, "Respiratory allergies in the elderly : findings from the Korean Longitudinal Study on Health and Aging phase I study(2005–2006)", Asia Pac Allergy, 7, pp.185~192 (2017)
  5. Holgate ST, "A look at the pathogenesis of asthma: the need for a change in direction", Discov Med, 9, pp.439~447 (2010)
  6. 김경원, "Lessons Learned From GWAS of Asthma", Allergy, Asthma & Immunology Research, 11(2), pp.170~187 (2019), 대한천식알레르기학회
  7. Thomsen SF, "Genetics of asthma : an introduction for the clinician", Eur Clin Respir J, 2, pp.24643~ (2015)
  8. Murrison LB, "Environmental exposures and mechanisms in allergy and asthma development", J Clin Invest, 129, pp.1504~1515 (2019)
  9. Man WH, "The microbiota of the respiratory tract : gatekeeper to respiratory health", Nat Rev Microbiol, 15, pp.259~270 (2017)
  10. Giavina-Bianchi P, "United airway disease : current perspectives", J Asthma Allergy, 9, pp.93~100 (2016)
  11. Charlson ES, "Topographical continuity of bacterial populations in the healthy human respiratory tract", Am J Respir Crit Care Med, 184, pp.957~963 (2011)
  12. Abdel-Aziz MI, "The crosstalk between microbiome and asthma : exploring associations and challenges", Clin Exp Allergy, 49, pp.1067~1086 (2019)
  13. Song WJ, "Staphylococcal enterotoxin sensitization in a community-based population : a potential role in adult-onset asthma", Clin Exp Allergy, 44, pp.553~562 (2014)
  14. Song WJ, "Staphylococcal enterotoxin IgE sensitization in late-onset severe eosinophilic asthma in the elderly", Clin Exp Allergy, 46, pp.411~421 (2016)
  15. Song WJ, "Staphylococcal enterotoxin specific IgE and asthma : a systematic review and meta-analysis", Asia Pac Allergy, 3, pp.120~126 (2013)
  16. NIH HMP Working Group, "The NIH Human Microbiome Project", Genome Res, 19, pp.2317~2323 (2009)
  17. Sender R, "Revised estimates for the number of human and bacteria cells in the body", PLoS Biol, 14, pp.e1002533~ (2016)
  18. Allaband C, "Microbiome 101 : studying, analyzing, and interpreting gut microbiome data for clinicians", Clin Gastroenterol Hepatol, 17, pp.218~230 (2019)
  19. Carr TF, "Eosinophilic and noneosinophilic asthma", Am J Respir Crit Care Med, 197, pp.22~37 (2018)
  20. Brusselle GG, "Eosinophils in the spotlight : eosinophilic airway inflammation in nonallergic asthma", Nat Med, 19, pp.977~979 (2013)
  21. Maes T, "Targeting interleukin-4 in asthma: lost in translation?", Am J Respir Cell Mol Biol, 47, pp.261~270 (2012)
  22. van Veen IH, "Consistency of sputum eosinophilia in difficult-to-treat asthma : a 5-year follow-up study", J Allergy Clin Immunol, 124, pp.615~617 (2009)
  23. Walker JA, "Innate lymphoid cells--how did we miss them", Nat Rev Immunol, 13, pp.75~87 (2013)
  24. Pelly VS, "IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection", Mucosal Immunol, 9, pp.1407~1417 (2016)
  25. Winkler C, "Activation of group 2 innate lymphoid cells after allergen challenge in asthmatic patients", J Allergy Clin Immunol, 144, pp.61.e7~69.e7 (2019)
  26. Kaur R, "Phenotypes and endotypes of adult asthma : moving toward precision medicine", J Allergy Clin Immunol, 144, pp.1~12 (2019)
  27. Peters SP, "Asthma phenotypes : nonallergic(intrinsic)asthma", J Allergy Clin Immunol Pract, 2, pp.650~665 (2014)
  28. Baos S, "Nonallergic asthma and its severity : biomarkers for its discrimination in peripheral samples", Front Immunol, 9, pp.1416~ (2018)
  29. Liu L, "Chitinaselike protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations", Respir Res, 20, pp.95~ (2019)
  30. Chen JH, "IL-17 protein levels in both induced sputum and plasma are increased in stable but not acute asthma individuals with obesity", Respir Med, 121, pp.48~58 (2016)
  31. Ntontsi P, "Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma : comparison with different sputum phenotypes", Allergy, 72, pp.1761~1767 (2017)
  32. Demarche S, "Detailed analysis of sputum and systemic inflammation in asthma phenotypes : are paucigranulocytic asthmatics really non-inflammatory", BMC Pulm Med, 16, pp.46~ (2016)
  33. Irvin C, "Increased frequency of dual-positive TH2", TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma, 2014, pp.134, 1175.e7~1186.e7
  34. Simpson JL, "Clarithromycin targets neutrophilic airway inflammation in refractory asthma", Am J Respir Crit Care Med, 177, pp.148~155 (2008)
  35. Ratner AJ, "Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces", Proc Natl Acad Sci U S A, 102, pp.3429~3434 (2005)
  36. Bachert C, "Staphylococcus aureus and its IgE-inducing enterotoxins in asthma : current knowledge", Eur Respir J, 55, pp.1901592~ (2020)
  37. Huang YJ, "The airway microbiome in patients with severe asthma : associations with disease features and severity", J Allergy Clin Immunol, 136, pp.874~884 (2015)
  38. Groneberg DA, "Distribution of respiratory mucin proteins in human nasal mucosa", Laryngoscope, 113, pp.520~524 (2003)
  39. Ali MS, "Upper airway mucin gene expression : a review", Laryngoscope, 117, pp.932~938 (2007)
  40. Takeyama K, "Relationship of epidermal growth factor receptors to goblet cell production in human bronchi", Am J Respir Crit Care Med, 163, pp.511~516 (2001)
  41. Mao YJ, "Increased expression of MUC5AC and MUC5B promoting bacterial biofilm formation in chronic rhinosinusitis patients", Auris Nasus Larynx, 42, pp.294~298 (2015)
  42. Dohrman A, "Mucin gene(MUC 2 and MUC 5AC)upregulation by Gram-positive and Gram-negative bacteria", Biochim Biophys Acta, 1406, pp.251~259 (1998)
  43. Shuter J, "Staphylococcus aureus binding to human nasal mucin", Infect Immun, 64, pp.310~318 (1996)
  44. Cohn L, "Cytokine regulation of mucus production in a model of allergic asthma", Novartis Found Symp, 248, pp.201~213 (2002)
  45. Hiemstra PS, "The innate immune function of airway epithelial cells in inflammatory lung disease", Eur Respir J, 45, pp.1150~1162 (2015)
  46. Niyonsaba F, "Evaluation of the effects of peptide antibiotics human beta-defensins-1", -2 and LL-37 on histamine release and prostaglandin D(2)production from mast cells, 2001, pp.31, 1066~1075
  47. Mahdavinia M, "A comprehensive review of the nasal microbiome in chronic rhinosinusitis(CRS)", Clin Exp Allergy, 46, pp.21~41 (2016)
  48. Vareille M, "The airway epithelium : soldier in the fight against respiratory viruses", Clin Microbiol Rev, 24, pp.210~229 (2011)
  49. Zakeri A, "Dual role of Toll-like receptors in human and experimental asthma models", Front Immunol, 9, pp.1027~ (2018)
  50. Dong Z, "Holding the inflammatory system in check : TLRs and their targeted therapy in asthma", Mediators Inflamm, 2016, pp.2180417~ (2016)
  51. Purevsuren Losol, "Genetic variants in the TLR‐related pathway and smoking exposure alter the upper airway microbiota in adult asthmatic patients", Allergy, 76(10), pp.3217~3220 (2021), Wiley[DOI]
  52. Askarian F, "Staphylococcus aureus modulation of innate immune responses through Toll-like(TLR), (NOD)-like(NLR)and C-type lectin(CLR)receptors", FEMS Microbiol Rev, 42, pp.656~671 (2018)
  53. Ritchie ND, "IL-17 signalling restructures the nasal microbiome and drives dynamic changes following Streptococcus pneumoniae colonization", BMC Genomics, 18, pp.807~ (2017)
  54. Baba S, "T-cell phenotypes in chronic rhinosinusitis with nasal polyps in Japanese patients", Allergy Asthma Clin Immunol, 11, pp.33~ (2015)
  55. Jackson DJ, "IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo", Am J Respir Crit Care Med, 190, pp.1373~1382 (2014)
  56. Walford HH, "Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness", Clin Immunol, 155, pp.126~135 (2014)
  57. de Steenhuijsen Piters WA, "The role of the local microbial ecosystem in respiratory health and disease", Philos Trans R Soc Lond B Biol Sci, 370, pp.20140294~ (2015)
  58. Chen, Chao-Hsuan, "An Innate Bactericidal Oleic Acid Effective Against Skin Infection of Methicillin-Resistant Staphylococcus aureus: A Therapy Concordant with Evolutionary Medicine", Journal of Microbiology and Biotechnology, 21(4), pp.391~399 (2011), 한국미생물·생명공학회
  59. Harriott MM, "Candida albicans and Staphylococcus aureus form polymicrobial biofilms : effects on antimicrobial resistance", Antimicrob Agents Chemother, 53, pp.3914~3922 (2009)
  60. Bellinghausen C, "Exposure to common respiratory bacteria alters the airway epithelial response to subsequent viral infection", Respir Res, 17, pp.68~ (2016)
  61. Human Microbiome Project Consortium, "Structure, function and diversity of the healthy human microbiome", Nature, 486, pp.207~214 (2012)
  62. Zhou Y, "Exploration of bacterial community classes in major human habitats", Genome Biol, 15, pp.R66~ (2014)
  63. Biswas K, "The nasal microbiota in health and disease : variation within and between subjects", Front Microbiol, 9, pp.134~ (2015)
  64. Polosa R, "Smoking and asthma : dangerous liaisons", Eur Respir J, 41, pp.716~726 (2013)
  65. Ito K, "Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages", FASEB J, 15, pp.1110~1112 (2001)
  66. Arnson Y, "Effects of tobacco smoke on immunity, inflammation and autoimmunity", J Autoimmun, 34, pp.J258~J265 (2010)
  67. Sapkota AR, "Human pathogens abundant in the bacterial metagenome of cigarettes", Environ Health Perspect, 118, pp.351~356 (2010)
  68. De Boeck I, "Comparing the healthy nose and nasopharynx microbiota reveals continuity as well as nichespecificity", Front Microbiol, 8, pp.2372~ (2017)
  69. Qin T, "High-level PM2. 5", PM10 exposure is associated with alterations in the human pharyngeal microbiota composition, 2019, pp.10, 54~
  70. Charlson ES, "Disordered microbial communities in the upper respiratory tract of cigarette smokers", PLoS One, 5, pp.e15216~ (2010)
  71. Munck C, "Smoking cessation and the microbiome in induced sputum samples from cigarette smoking asthma patients", PLoS One, 11, pp.e0158622~ (2016)
  72. Huang C, "Smoking and microbiome in oral, airway, gut and some systemic diseases", J Transl Med, 17, pp.225~ (2019)
  73. Guarnieri M, "Outdoor air pollution and asthma", Lancet, 383, pp.1581~1592 (2014)
  74. De Grove KC, "Insights in particulate matter-induced allergic airway inflammation : focus on the epithelium", Clin Exp Allergy, 48, pp.773~786 (2018)
  75. Liu H, "Effect of air pollution on the total bacteria and pathogenic bacteria in different sizes of particulate matter", Environ Pollut, 233, pp.483~493 (2018)
  76. Mostafavi N, "The mediating effect of immune markers on the association between ambient air pollution and adult-onset asthma", Sci Rep, 9, pp.8818~ (2019)
  77. Whelan R, "Role and regulation of interleukin-1molecules in pro-asthmatic sensitised airway smooth muscle", Eur Respir J, 24, pp.559~567 (2004)
  78. Godwin MS, "IL-1RA regulates immunopathogenesis during fungal-associated allergic airway inflammation", JCI Insight, 4, pp.e129055~ (2019)
  79. Igartua C, "Host genetic variation in mucosal immunity pathways influences the upper airway microbiome", Microbiome, 5, pp.16~ (2017)
  80. Lee JJ, "Different upper airway microbiome and their functional genes associated with asthma in young adults and elderly individuals", Allergy, 74, pp.709~719 (2019)
  81. Gan W, "The difference in nasal bacterial microbiome diversity between chronic rhinosinusitis patients with polyps and a control population", Int Forum Allergy Rhinol, 9, pp.582~592 (2019)
  82. Chalermwatanachai T, "Chronic rhinosinusitis with nasal polyps is characterized by dysbacteriosis of the nasal microbiota", Sci Rep, 8, pp.7926~ (2018)
  83. Purevsuren Losol, "IL-5 Promoter Polymorphism Enhances IgE Responses to Staphylococcal Superantigens in Adult Asthmatics", Allergy, Asthma & Immunology Research, 5(2), pp.106~109 (2013), 대한천식알레르기학회
  84. Ramakrishnan VR, "Sinus microbiota varies among chronic rhinosinusitis phenotypes and predicts surgical outcome", J Allergy Clin Immunol, 136, pp.334.e1~342.e1 (2015)
  85. Hilty M, "Disordered microbial communities in asthmatic airways", PLoS One, 5, pp.e8578~ (2010)
  86. Fazlollahi M, "The nasal microbiome in asthma", J Allergy Clin Immunol, 142, pp.834.e2~843.e2 (2018)
  87. Yang HJ, "Association of nasal microbiome and asthma control in patients with chronic rhinosinusitis", Clin Exp Allergy, 48, pp.1744~1747 (2018)
  88. Zhang Q, "Airway microbiota in severe asthma and relationship to asthma severity and phenotypes", PLoS One, 11, pp.e0152724~ (2016)
  89. Denner DR, "Corticosteroid therapy and airflow obstruction influence the bronchial microbiome, which is distinct from that of bronchoalveolar lavage in asthmatic airways", J Allergy Clin Immunol, 137, pp.1398.e3~1405.e3 (2016)
  90. Biesbroek G, "Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children", Am J Respir Crit Care Med, 190, pp.1283~1292 (2014)
  91. Ta LDH, "Establishment of the nasal microbiota in the first 18 months of life : correlation with earlyonset rhinitis and wheezing", J Allergy Clin Immunol, 142, pp.86~95 (2018)
  92. Miraglia Del Giudice M, "Bifidobacterium mixture(B longum BB536, B infantis M-63, B breve M-16V)treatment in children with seasonal allergic rhinitis and intermittent asthma", Ital J Pediatr, 43, pp.25~ (2017)
  93. Martens K, "Probiotics for the airways : potential to improve epithelial and immune homeostasis", Allergy, 73, pp.1954~1963 (2018)
  94. Ishida Y, "Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis : a double-blind, placebocontrolled study", J Dairy Sci, 88, pp.527~533 (2005)
  95. Xu LZ, "Combination of specific allergen and probiotics induces specific regulatory B cells and enhances specific immunotherapy effect on allergic rhinitis", Oncotarget, 7, pp.54360~54369 (2016)
  96. Singh A, "Immune-modulatory effect of probiotic Bifidobacterium lactis NCC2818 in individuals suffering from seasonal allergic rhinitis to grass pollen : an exploratory, randomized, placebocontrolled clinical trial", Eur J Clin Nutr, 67, pp.161~167 (2013)
  97. Dennis-Wall JC, "Probiotics(Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2)improve rhinoconjunctivitis-specific quality of life in individuals with seasonal allergies : a double-blind, placebo-controlled, randomized trial", Am J Clin Nutr, 105, pp.758~767 (2017)
  98. Mårtensson A, "Effects of a honeybee lactic acid bacterial microbiome on human nasal symptoms, commensals, and biomarkers", Int Forum Allergy Rhinol, 6, pp.956~963 (2016)
  99. Pérez-Cobas AE, "Gut microbiota disturbance during antibiotic therapy : a multi-omic approach", Gut, 62, pp.1591~1601 (2013)
  100. Suzuki H, "Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells", Laryngoscope, 107, pp.1661~1666 (1997)
  101. Desaki M, "Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells", Biochem Biophys Res Commun, 267, pp.124~128 (2000)
  102. Ferrer M, "Antibiotic use and microbiome function", Biochem Pharmacol, 134, pp.114~126 (2017)
  103. de Oliveira IS, "Azithromycin for the treatment of eosinophilic nasal polyposis: clinical and histologic analysis", Allergy Rhinol(Providence), 7, pp.55~61 (2016)
  104. Gibson PG, "Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma(AMAZES) : a randomised, double-blind, placebo-controlled trial", Lancet, 390, pp.659~668 (2017)
  105. Johnston SL, "Azithromycin for acute exacerbations of asthma : the AZALEA randomized clinical trial", JAMA Intern Med, 176, pp.1630~1637 (2016)
  106. Feazel LM, "Microbiome complexity and Staphylococcus aureus in chronic rhinosinusitis", Laryngoscope, 122, pp.467~472 (2012)
  107. Liu CM, "Medical therapy reduces microbiota diversity and evenness in surgically recalcitrant chronic rhinosinusitis", Int Forum Allergy Rhinol, 3, pp.775~781 (2013)
  108. Yao J, "A pathogen-selective antibiotic minimizes disturbance to the microbiome", Antimicrob Agents Chemother, 60, pp.4264~4273 (2016)
  109. Lohia S, "Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis : a meta-analysis", Allergy, 68, pp.569~579 (2013)
  110. Ramakrishnan VR, "Determinants of the nasal microbiome: pilot study of effects of intranasal medication use", Allergy Rhinol(Providence), 9 (2018)
  111. Chung KF, "Airway microbial dysbiosis in asthmatic patients: a target for prevention and treatment?", J Allergy Clin Immunol, 139, pp.1071~1081 (2017)

관련 논문AI추천

천식과 만성폐쇄성폐질환에서 마이크로바이옴 연구강혜련, 김병근, 이진국, 정지예, 조상헌대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2016 · 제4권 제5호The Interplay between Host Immunity and Respiratory Viral Infection in Asthma Exacerbation박성옥, 어성국, 최진영, Erdenebileg Uyangaa, Ferdaus Mohd Altaf Hossain대한면역학회 · Immune Network2019 · 제19권 제5호Gut microbiota dysbiosis and its impact on asthma and other lung diseases: potential therapeutic approaches손경희, Hye-Ryun Kang, Young-Chan Kim대한내과학회 · The Korean Journal of Internal Medicine2024 · 제39권 제5호Interactions between NCR + ILC3s and the Microbiome in the Airways Shape Asthma Severity강혜련, 김영찬, 김지현, 김혜영, 박재현, 배용수, 백민경, 손경희, 양시영, 원성호, 이하나, 정두현, 조상현, 최성미, 함종호대한면역학회 · Immune Network2021 · 제21권 제4호Compositional Alterations of the Nasal Microbiome and Staphylococcus aureus–Characterized Dysbiosis in the Nasal Mucosa of Patients With Allergic Rhinitis김원용, 김종화, 김현직, 한선아대한이비인후과학회 · Clinical and Experimental Otorhinolaryngology2022 · 제15권 제4호Beyond Hygiene: Commensal Microbiota and Allergic Diseases김광순, 홍성욱, Surh Charles D.대한면역학회 · Immune Network2017 · 제17권 제1호

이 간행물의 다른 논문 (6건)

Toll-like Receptor 2 in Autoimmune InflammationReynolds Joseph M., Marks Kathryne E., Cho Kaylin, Stickling Courtneypp. 1-13Gut-Brain Connection: Microbiome, Gut Barrier, and Environmental Sensors장선영, 곽민규pp. 1-18Mechanisms Underlying the Role of Myeloid-Derived Suppressor Cells in Clinical Diseases: Good or BadZhang Junfeng, Ge Yongtong, Cheng Dalei, Jia Qingzhi, Xiong Huabaopp. 1-22Effect of Human or Mouse IL-7 on the Homeostasis of Porcine T Lymphocytes김지수, 박영호, 김선욱, 김상훈, 김현경, 정용우, 장준호, 최한별, 정강진, 박성필, 홍지화, 손려강, 강필용pp. 1-13Enriching CCL3 in the Tumor Microenvironment Facilitates T cell Responses and Improves the Efficacy of Anti-PD-1 Therapy문지현, 이준형, 박효진, 하상준, 강태건pp. 1-16
원문 보기